Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment.

Orsi E, Bonora E, Solini A, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Zerbini G, Morano S, Nicolucci A, Penno G, Pugliese G.

J Clin Med. 2020 Jan 17;9(1). pii: E246. doi: 10.3390/jcm9010246.

2.

miR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic Potential.

Cavallari C, Figliolini F, Tapparo M, Cedrino M, Trevisan A, Positello L, Rispoli P, Solini A, Migliaretti G, Camussi G, Brizzi MF.

Sci Rep. 2020 Jan 20;10(1):706. doi: 10.1038/s41598-019-55783-7.

3.

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study.

Fadini GP, Li Volsi P, Devangelio E, Poli M, Cazzetta G, Felace G, Avogaro A; DARWIN-T2D Network.

J Endocrinol Invest. 2020 Mar;43(3):329-336. doi: 10.1007/s40618-019-01110-w. Epub 2019 Sep 12.

PMID:
31515744
4.

The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature.

Solini A, Seghieri M, Giannini L, Biancalana E, Parolini F, Rossi C, Dardano A, Taddei S, Ghiadoni L, Bruno RM.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4253-4263. doi: 10.1210/jc.2019-00706.

PMID:
31162549
5.

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study.

Solini A, Penno G, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Baroni MG, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.

BMC Med. 2019 Apr 25;17(1):83. doi: 10.1186/s12916-019-1313-x.

6.

Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study.

Fadini GP, Sciannameo V, Franzetti I, Bottigliengo D, D'Angelo P, Vinci C, Berchialla P, Arena S, Buzzetti R, Avogaro A; DARWIN-T2D network.

Diabetes Obes Metab. 2019 Aug;21(8):1886-1894. doi: 10.1111/dom.13747. Epub 2019 May 8.

7.

Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes.

Clapp C, Diaz-Lezama N, Adan-Castro E, Ramirez-Hernandez G, Moreno-Carranza B, Sarti AC, Falzoni S, Solini A, Di Virgilio F.

Acta Diabetol. 2019 Sep;56(9):1031-1036. doi: 10.1007/s00592-019-01343-4. Epub 2019 Apr 13.

PMID:
30982154
8.

Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complications.

Solini A, Novak I.

Curr Opin Pharmacol. 2019 Aug;47:75-81. doi: 10.1016/j.coph.2019.02.009. Epub 2019 Apr 5. Review.

PMID:
30954933
9.

Alterations in Carotid Parameters in ApoE-/- Mice Treated with a High-Fat Diet: A Micro-ultrasound Analysis.

Di Lascio N, Kusmic C, Rossi C, Solini A, Faita F.

Ultrasound Med Biol. 2019 Apr;45(4):980-988. doi: 10.1016/j.ultrasmedbio.2018.12.005. Epub 2019 Feb 1.

PMID:
30712947
10.

Renal Resistive Index Predicts Post-Bariatric Surgery Renal Outcome in Nondiabetic Individuals with Severe Obesity.

Solini A, Seghieri M, Santini E, Giannini L, Biancalana E, Taddei S, Volterrani D, Bruno RM.

Obesity (Silver Spring). 2019 Jan;27(1):68-74. doi: 10.1002/oby.22355. Epub 2018 Dec 5.

11.

Phthalates Exposure as Determinant of Albuminuria in Subjects With Type 2 Diabetes: A Cross-Sectional Study.

Mengozzi A, Carli F, Biancalana E, Della Latta V, Seghieri M, Gastaldelli A, Solini A.

J Clin Endocrinol Metab. 2019 May 1;104(5):1491-1499. doi: 10.1210/jc.2018-01797.

PMID:
30462244
12.

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD.

Seghieri M, Christensen AS, Andersen A, Solini A, Knop FK, Vilsbøll T.

Front Endocrinol (Lausanne). 2018 Nov 6;9:649. doi: 10.3389/fendo.2018.00649. eCollection 2018. Review.

13.

Periodontitis affects glucoregulatory hormones in severely obese individuals.

Solini A, Suvan J, Santini E, Gennai S, Seghieri M, Masi S, Petrini M, D'Aiuto F, Graziani F.

Int J Obes (Lond). 2019 May;43(5):1125-1129. doi: 10.1038/s41366-018-0253-4. Epub 2018 Nov 19.

14.

A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes.

Zusi C, Trombetta M, Bonetti S, Dauriz M, Boselli ML, Trabetti E, Malerba G, Penno G, Zoppini G, Bonora E, Solini A, Bonadonna RC.

Diabetes Res Clin Pract. 2018 Oct;144:137-143. doi: 10.1016/j.diabres.2018.08.013. Epub 2018 Aug 25.

PMID:
30153470
15.

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study.

Fadini GP, Solini A, Manca ML, Penno G, Gatti A, Anichini R, Del Prato S, Avogaro A; DARWIN-T2D Network.

Diabetes Obes Metab. 2019 Feb;21(2):252-260. doi: 10.1111/dom.13508. Epub 2018 Sep 21.

16.

Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study.

Fadini GP, Solini A, Manca ML, Zatti G, Karamouzis I, Di Benedetto A, Frittitta L, Avogaro A; DARWIN-T2D Network.

Acta Diabetol. 2018 Nov;55(11):1121-1129. doi: 10.1007/s00592-018-1194-z. Epub 2018 Aug 9.

PMID:
30090961
17.

Islet-Derived eATP Fuels Autoreactive CD8+ T Cells and Facilitates the Onset of Type 1 Diabetes.

Tezza S, Ben Nasr M, D'Addio F, Vergani A, Usuelli V, Falzoni S, Bassi R, Dellepiane S, Fotino C, Rossi C, Maestroni A, Solini A, Corradi D, Giani E, Mameli C, Bertuzzi F, Pezzolesi MG, Wasserfall CH, Atkinson MA, Füchtbauer EM, Ricordi C, Folli F, Di Virgilio F, Pileggi A, Dhe-Paganon S, Zuccotti GV, Fiorina P.

Diabetes. 2018 Oct;67(10):2038-2053. doi: 10.2337/db17-1227. Epub 2018 Jul 31.

18.

Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.

Penno G, Solini A, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Scardapane M, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.

Diabetologia. 2018 Nov;61(11):2277-2289. doi: 10.1007/s00125-018-4691-2. Epub 2018 Jul 21.

PMID:
30032426
19.

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study.

Fadini GP, Bottigliengo D, D'Angelo F, Cavalot F, Bossi AC, Zatti G, Baldi I, Avogaro A; DARWIN-T2D Network.

Diabetes Ther. 2018 Aug;9(4):1477-1490. doi: 10.1007/s13300-018-0452-y. Epub 2018 Jun 1.

20.

Ultrasonographic Characterization of the db/db Mouse: An Animal Model of Metabolic Abnormalities.

Faita F, Di Lascio N, Rossi C, Kusmic C, Solini A.

J Diabetes Res. 2018 Mar 8;2018:4561309. doi: 10.1155/2018/4561309. eCollection 2018.

Supplemental Content

Loading ...
Support Center